Targeting immune privilege to prevent pathogenic neovascularization

Targeting immune privilege to prevent pathogenic neovascularization

Item
http://www.wikidata.org/entity/Q33994168
Inflammation and its role in age-related macular degenerationLack of thrombospondin 1 and exacerbation of choroidal neovascularizationAge-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degenerationTargeting Neovascularization in Ischemic Retinopathy: Recent AdvancesDoxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularizationRAGE regulates immune cell infiltration and angiogenesis in choroidal neovascularization.Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in MiceImpaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice.Cytokines and angiogenesis in the corpus luteumSeeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos.Good news-bad news: the Yin and Yang of immune privilege in the eye.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration.FAS Gene Copy Numbers are Associated with Susceptibility to Behçet Disease and VKH Syndrome in Han Chinese.
P2860

Targeting immune privilege to prevent pathogenic neovascularization

Item
http://www.wikidata.org/entity/Q33994168
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting immune privilege to prevent pathogenic neovascularization
@ast
Targeting immune privilege to prevent pathogenic neovascularization
@en
type
label
Targeting immune privilege to prevent pathogenic neovascularization
@ast
Targeting immune privilege to prevent pathogenic neovascularization
@en
prefLabel
Targeting immune privilege to prevent pathogenic neovascularization
@ast
Targeting immune privilege to prevent pathogenic neovascularization
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting immune privilege to prevent pathogenic neovascularization
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932